Xylem (XYL) reported second-quarter 2026 revenue of $2.3 billion, up 2% on a reported basis and 1% organically. Orders were $3.1 billion, up 42% on a reported basis and 41% organically.
Net income attributable to Xylem was $263 million, or $1.11 per share. The company now forecasts full-year 2026 revenue of approximately $9.2 billion and adjusted earnings per share of $5.55 to $5.70.
- Second-quarter revenue was $2.336 billion, compared with $2.301 billion a year earlier.
- Net income attributable to Xylem was $263 million, compared with $226 million a year earlier.
- Basic and diluted earnings per share were both $1.11, compared with $0.93 a year earlier.
- Adjusted EBITDA margin was 23.3%, up 150 basis points year over year.
- Full-year 2026 revenue guidance is approximately $9.2 billion, up approximately 2% on a reported basis.
